Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1994 1
1995 1
1997 2
1998 2
2000 2
2001 3
2003 2
2004 3
2005 3
2006 3
2007 2
2008 2
2010 1
2011 3
2012 4
2013 4
2014 10
2015 4
2016 11
2017 15
2018 14
2019 15
2020 18
2021 15
2022 19
2023 16
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Review of gene therapies for age-related macular degeneration.
Khanani AM, Thomas MJ, Aziz AA, Weng CY, Danzig CJ, Yiu G, Kiss S, Waheed NK, Kaiser PK. Khanani AM, et al. Among authors: yiu g. Eye (Lond). 2022 Feb;36(2):303-311. doi: 10.1038/s41433-021-01842-1. Epub 2022 Jan 11. Eye (Lond). 2022. PMID: 35017696 Free PMC article. Review.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Human T cell generation is restored in CD3δ severe combined immunodeficiency through adenine base editing.
McAuley GE, Yiu G, Chang PC, Newby GA, Campo-Fernandez B, Fitz-Gibbon ST, Wu X, Kang SL, Garibay A, Butler J, Christian V, Wong RL, Everette KA, Azzun A, Gelfer H, Seet CS, Narendran A, Murguia-Favela L, Romero Z, Wright N, Liu DR, Crooks GM, Kohn DB. McAuley GE, et al. Among authors: yiu g. Cell. 2023 Mar 30;186(7):1398-1416.e23. doi: 10.1016/j.cell.2023.02.027. Epub 2023 Mar 20. Cell. 2023. PMID: 36944331 Free PMC article.
Reply.
Willoughby AS, Vuong VS, Cunefare D, Farsiu S, Noronha G, Danis RP, Yiu G. Willoughby AS, et al. Among authors: yiu g. Am J Ophthalmol. 2018 May;189:178. doi: 10.1016/j.ajo.2018.03.002. Epub 2018 Mar 22. Am J Ophthalmol. 2018. PMID: 29576184 No abstract available.
Inverted Hypopyon.
Yiu G, Emami-Naeni P. Yiu G, et al. JAMA Ophthalmol. 2019 Jun 1;137(6):e185256. doi: 10.1001/jamaophthalmol.2018.5256. Epub 2019 Jun 13. JAMA Ophthalmol. 2019. PMID: 31194236 No abstract available.
Subretinal hemorrhage.
Yiu G, Mahmoud TH. Yiu G, et al. Dev Ophthalmol. 2014;54:213-22. doi: 10.1159/000360469. Epub 2014 Aug 26. Dev Ophthalmol. 2014. PMID: 25196772 Review.
Conjunctival melanoma.
Yiu G, Cummings TJ, Mruthyunjaya P. Yiu G, et al. JAMA Ophthalmol. 2014 Dec;132(12):1432. doi: 10.1001/jamaophthalmol.2014.585. JAMA Ophthalmol. 2014. PMID: 25340828 No abstract available.
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
Choroidal osteomas.
Yiu G, Young LH. Yiu G, et al. JAMA Ophthalmol. 2013 Jan;131(1):124. doi: 10.1001/jamaophthalmol.2013.568. JAMA Ophthalmol. 2013. PMID: 23307230 No abstract available.
159 results